Abstract
This research focuses on the synthesis of composite CoFe 2O 4 (CoF) nanoparticles coated with SiO 2 using hydroxyapatite (HAp) as a template (CoFSi) and the pH controlled release of indomethacin (IMC) drug from this nanocomposite. The formation of the CoFe 2O 4-HAp (CoFHAp) nanoparticles and of the CoFe 2O 4@SiO 2 (CoFSi) nanoparticles were monitored using XRD, FT-IR, that TEM, SEM, and ED studies. The magnetic properties are measured with a VSM. The TEM images showed the CoFe 2O 4 to have a core–shell structure encapsulated by a silica coating with an average size of 50 nm. BET showed the mean pore sizes of the silica shell to be approximately 10–20 nm and the surface area to be 212.8 m 2 g −1. Magnetization ( M s ) and remnant ( M r ) magnetic properties of CoFSi nanocomposite decreased upon silica coating (from ∼14 to 2 emu g −1 for M s of CoF and CoFSi, respectively). In contrast, the coercivity ( H c ) of the uncoated CoFe 2O 4 (317 Oe) is lower than that of the coated nanocomposites (1250 Oe of CoFSi). In vitro drug loading of the CoFSi nanoparticles and its pH-responsive (pH = 4.0 and 7.0) controlled release were investigated using IMC as a model drug. It was seen that the release of the IMC drug was significantly faster at a pH of 4.0 compared to that at a neutral pH 7.0. Furthermore, the lower concentration of ions release (iron and cobalt) from CoFSi was observed after aging for 50 h.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
